218 related articles for article (PubMed ID: 22362582)
1. The influence of health and lifestyle characteristics on the relation of serum 25-hydroxyvitamin D with risk of colorectal and breast cancer in postmenopausal women.
Neuhouser ML; Manson JE; Millen A; Pettinger M; Margolis K; Jacobs ET; Shikany JM; Vitolins M; Adams-Campbell L; Liu S; LeBlanc E; Johnson KC; Wactawski-Wende J
Am J Epidemiol; 2012 Apr; 175(7):673-84. PubMed ID: 22362582
[TBL] [Abstract][Full Text] [Related]
2. Circulating 25-Hydroxyvitamin D Concentration and Risk of Breast, Prostate, and Colorectal Cancers: The Melbourne Collaborative Cohort Study.
Heath AK; Hodge AM; Ebeling PR; Eyles DW; Kvaskoff D; Buchanan DD; Giles GG; Williamson EJ; English DR
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):900-908. PubMed ID: 30842127
[TBL] [Abstract][Full Text] [Related]
3. Calcium plus vitamin D supplementation and the risk of breast cancer.
Chlebowski RT; Johnson KC; Kooperberg C; Pettinger M; Wactawski-Wende J; Rohan T; Rossouw J; Lane D; O'Sullivan MJ; Yasmeen S; Hiatt RA; Shikany JM; Vitolins M; Khandekar J; Hubbell FA;
J Natl Cancer Inst; 2008 Nov; 100(22):1581-91. PubMed ID: 19001601
[TBL] [Abstract][Full Text] [Related]
4. Serum 25-hydroxyvitamin D concentrations and postmenopausal breast cancer risk: a nested case control study in the Cancer Prevention Study-II Nutrition Cohort.
McCullough ML; Stevens VL; Patel R; Jacobs EJ; Bain EB; Horst RL; Gapstur SM; Thun MJ; Calle EE
Breast Cancer Res; 2009; 11(4):R64. PubMed ID: 19715600
[TBL] [Abstract][Full Text] [Related]
5. Plasma vitamin D metabolites and risk of colorectal cancer in women.
Feskanich D; Ma J; Fuchs CS; Kirkner GJ; Hankinson SE; Hollis BW; Giovannucci EL
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1502-8. PubMed ID: 15342452
[TBL] [Abstract][Full Text] [Related]
6. Serum vitamin D, vitamin D binding protein, and risk of colorectal cancer.
Anic GM; Weinstein SJ; Mondul AM; Männistö S; Albanes D
PLoS One; 2014; 9(7):e102966. PubMed ID: 25036524
[TBL] [Abstract][Full Text] [Related]
7. Re: "The influence of health and lifestyle characteristics on the relation of serum 25-hydroxyvitamin D with risk of colorectal and breast cancer in postmenopausal women".
Grant WB
Am J Epidemiol; 2012 Nov; 176(9):838. PubMed ID: 23045473
[No Abstract] [Full Text] [Related]
8. Serum vitamin D concentration and prostate cancer risk: a nested case-control study.
Ahn J; Peters U; Albanes D; Purdue MP; Abnet CC; Chatterjee N; Horst RL; Hollis BW; Huang WY; Shikany JM; Hayes RB;
J Natl Cancer Inst; 2008 Jun; 100(11):796-804. PubMed ID: 18505967
[TBL] [Abstract][Full Text] [Related]
9. Serum 25-hydroxyvitamin D, vitamin D binding protein and risk of colorectal cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
Weinstein SJ; Purdue MP; Smith-Warner SA; Mondul AM; Black A; Ahn J; Huang WY; Horst RL; Kopp W; Rager H; Ziegler RG; Albanes D
Int J Cancer; 2015 Mar; 136(6):E654-64. PubMed ID: 25156182
[TBL] [Abstract][Full Text] [Related]
10. Circulating Vitamin D Levels and Risk of Colorectal Cancer in Women.
Chandler PD; Buring JE; Manson JE; Giovannucci EL; Moorthy MV; Zhang S; Lee IM; Lin JH
Cancer Prev Res (Phila); 2015 Aug; 8(8):675-82. PubMed ID: 25813525
[TBL] [Abstract][Full Text] [Related]
11. Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study.
Jenab M; Bueno-de-Mesquita HB; Ferrari P; van Duijnhoven FJ; Norat T; Pischon T; Jansen EH; Slimani N; Byrnes G; Rinaldi S; Tjønneland A; Olsen A; Overvad K; Boutron-Ruault MC; Clavel-Chapelon F; Morois S; Kaaks R; Linseisen J; Boeing H; Bergmann MM; Trichopoulou A; Misirli G; Trichopoulos D; Berrino F; Vineis P; Panico S; Palli D; Tumino R; Ros MM; van Gils CH; Peeters PH; Brustad M; Lund E; Tormo MJ; Ardanaz E; Rodríguez L; Sánchez MJ; Dorronsoro M; Gonzalez CA; Hallmans G; Palmqvist R; Roddam A; Key TJ; Khaw KT; Autier P; Hainaut P; Riboli E
BMJ; 2010 Jan; 340():b5500. PubMed ID: 20093284
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma.
Gandini S; Boniol M; Haukka J; Byrnes G; Cox B; Sneyd MJ; Mullie P; Autier P
Int J Cancer; 2011 Mar; 128(6):1414-24. PubMed ID: 20473927
[TBL] [Abstract][Full Text] [Related]
13. Serum 25-hydroxyvitamin D and risk of breast cancer: results of a large population-based case-control study in Mexican women.
Fedirko V; Torres-Mejía G; Ortega-Olvera C; Biessy C; Angeles-Llerenas A; Lazcano-Ponce E; Saldaña-Quiroz VA; Romieu I
Cancer Causes Control; 2012 Jul; 23(7):1149-62. PubMed ID: 22622862
[TBL] [Abstract][Full Text] [Related]
14. Serum 25-hydroxyvitamin D concentrations and lung cancer risk in never-smoking postmenopausal women.
Cheng TD; Song X; Beresford SAA; Ho GYF; Johnson KC; Datta M; Chlebowski RT; Wactawski-Wende J; Qi L; Neuhouser ML
Cancer Causes Control; 2017 Oct; 28(10):1053-1063. PubMed ID: 28900765
[TBL] [Abstract][Full Text] [Related]
15. Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study.
Scarmo S; Afanasyeva Y; Lenner P; Koenig KL; Horst RL; Clendenen TV; Arslan AA; Chen Y; Hallmans G; Lundin E; Rinaldi S; Toniolo P; Shore RE; Zeleniuch-Jacquotte A
Breast Cancer Res; 2013 Feb; 15(1):R15. PubMed ID: 23442740
[TBL] [Abstract][Full Text] [Related]
16. Dose-response of serum 25-hydroxyvitamin D in association with risk of colorectal cancer: A meta-analysis.
Garland CF; Gorham ED
J Steroid Biochem Mol Biol; 2017 Apr; 168():1-8. PubMed ID: 27993551
[TBL] [Abstract][Full Text] [Related]
17. Serum 25-hydroxyvitamin D and breast cancer in the military: a case-control study utilizing pre-diagnostic serum.
Mohr SB; Gorham ED; Alcaraz JE; Kane CI; Macera CA; Parsons JK; Wingard DL; Horst R; Garland CF
Cancer Causes Control; 2013 Mar; 24(3):495-504. PubMed ID: 23296455
[TBL] [Abstract][Full Text] [Related]
18. Predictors of serum 25-hydroxyvitamin D concentrations among postmenopausal women: the Women's Health Initiative Calcium plus Vitamin D clinical trial.
Millen AE; Wactawski-Wende J; Pettinger M; Melamed ML; Tylavsky FA; Liu S; Robbins J; LaCroix AZ; LeBoff MS; Jackson RD
Am J Clin Nutr; 2010 May; 91(5):1324-35. PubMed ID: 20219959
[TBL] [Abstract][Full Text] [Related]
19. Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors?
Vrieling A; Seibold P; Johnson TS; Heinz J; Obi N; Kaaks R; Flesch-Janys D; Chang-Claude J
Int J Cancer; 2014 Jun; 134(12):2972-83. PubMed ID: 24272459
[TBL] [Abstract][Full Text] [Related]
20. A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer.
Wu K; Feskanich D; Fuchs CS; Willett WC; Hollis BW; Giovannucci EL
J Natl Cancer Inst; 2007 Jul; 99(14):1120-9. PubMed ID: 17623801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
